NEOVACC vaccine(University of Liverpool)

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameNEOVACC vaccine(University of Liverpool)

Drug Alias NameDoggybone personalised cancer DNA vaccine(University of Liverpool)NeoVACC personalised vaccine(University of Liverpool)dbPCV(University of Liverpool)

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Liverpool

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Liverpool

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell Lung

Inactive IndicationsN/A

Other Information

ATC CodeN/A